We describe three children who developed an osteosarcoma after receiving treatment for acute lymphoblastic leukemia, which included an allogeneic bone marrow transplant (BMT). We discuss the therapeutic options. None of the patients responded to conventional chemotherapy, but one patient given regorafenib showed a temporary response. We conclude that osteosarcoma after BMT has an aggressive course and it is worth further investigating multikinase inhibitors in this setting.
Get full access to this article
View all access options for this article.
References
1.
ChoiDK, HelenowskiI, HijiyaN. Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature. Int J Cancer. 2014; 135(8):1764–73.
2.
TubianaM. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol. 2009; 91:4–15.
3.
MeadowsA, FriedmanD, NegliaJ, et al.Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; 27:2356–62.
4.
OkadaA, HatoriM, HosakaM, et al.Secondary osteosarcoma arising after treatment for childhood hematologic malignancies. Ups J Med Sci. 2009; 114:249–55.
5.
ScheuermannA, PhelanR, BrowningM. Development of secondary osteosarcoma after TBI and allogeneic bone marrow transplant: a case series of 3 patients. J Pediatr Hematol Oncol. 2020; 42:e100–3.
6.
KebudiR, OzgerH, KizilocakH, et al.Osteosarcoma after hematopoietic stem cell transplantation in children and adolescents: case report and review of the literature. Pediatr Blood Cancer. 2016; 63(9):1664–6.
7.
UekiH, MaedaN, SekimizuM, et al.Osteosarcoma after bone marrow transplantation. J Pediatr Hematol Oncol. 2013; 35:134–8.
8.
ZilsK, BielackS. Osteosarcoma after bone marrow transplantation: still a challenge. J Pediatr Hematol Oncol. 2015; 37:74.
ShimodaK, KohK, UchinoS. A case of osteosarcoma after allogeneic bone marrow transplantation for chronic granulomatous disease. J Jpn Pediatr Soc. 2006; 111:912.
11.
BielackSS, RerinJS, DickerhoR, et al.Osteosarcoma after allogenic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS). Bone Marrow Transplant. 2003; 31:3539.
12.
AsaiT, MyouiA, FujimotoT, et al.Osteosarcoma after bone marrow transplantation for acute lymphoblastic leukemia. Int J Clin Oncol. 2002; 7:318–21.
13.
Favre-SchmuzigerG, HoferS, PasswegJ, et al.Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000; 25:895–8.
14.
Poustchi-AminM, LeonidasJC, ElkowitzSS. Simultaneous occurrence of osteosarcoma and osteochondroma following treatment of neuroblastoma with chemotherapy, radiotherapy and bone marrow transplantation. Pediatr Radiol. 1996; 26:155–7.
15.
FerrariS, RufferiP, CefaloG, et al.Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian Sarcoma Group Trial ISG/OS-1. J Clin Oncol. 2012; 30:2112–8.
16.
DuffaudF, MirO, Boudou-RouquetteP, et al.Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol. 2019; 20(1):120–33.
17.
DavisLE, BolejackV, RyanCW, et al.Randomized double-blind phase ii study of regorafenib in patients with metastatic osteosarcoma. J Clin Oncol. 2019; 37:1424–31.
18.
SmithLM, DonaldsonSS. Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. Oncology (Williston Park). 1991; 5:135–41; discussion 142, 147–8.
19.
BechlerJR, RobertsonWWJ, MeadowsAT, WomerRB. Osteosarcoma as a second malignant neoplasm in children. J Bone Joint Surg Am. 1992; 74:1079–83.
20.
HawkinsMM, DraperGJ, KingstonJE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer. 1987; 56:339–47.
NygaardR, GarwiczS, HaldorsenT, et al.Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO). Acta Paediatr Scand. 1991; 80:1220–8.
23.
LoningL, ZimmermannM, ReiterA, et al.Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 2000; 95:2770–5.
24.
GianniniL, IncandelaF, FioreM, et al.Radiation-induced sarcoma of the head and neck: a review of the literature. Front Oncol. 2018; 8:449.
25.
KoshyM, PaulinoAC, MaiWY, TehBS. Radiation-induced osteosarcomas in the pediatric population. Int J Radiat Oncol Biol Phys. 2005; 63(4):1169–74.
